Maravai names Trey Martin CEO, co-founder Carl Hull becomes Executive Chairman

MARAVAI LIFESCIENCES HOLDINGS, INC.

Martin appointed CEO effective Sept 30, 2022, succeeding Carl Hull who becomes Executive Chairman.
Martin previously SVP at Danaher, President of Integrated DNA Technologies; over 25 yrs in life sciences.
Martin receives base salary $750k, target bonus $937.5k for 2022, and equity awards totaling ~$17M.
Hull's base salary reduced to $500k; target bonus for 2022 remains $725k, subsequent years 100% of base.
Company to discuss transition on Q3 2022 earnings call scheduled for Nov 2.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William "Trey" Martin, III

Chief Executive Officer

MRVI · MARAVAI LIFESCIENCES HOLDINGS, INC.

Effective: 2022-09-30
Filed: October 3, 2022, 7:59 PM ET

On September 30, 2022, William “Trey” Martin, III was appointed Chief Executive Officer of Maravai LifeSciences Holdings, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William "Trey" Martin, III was appointed as Chief Executive Officer at MARAVAI LIFESCIENCES HOLDINGS, INC..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On September 30, 2022, William “Trey” Martin, III was appointed Chief Executive Officer of Maravai LifeSciences Holdings, Inc.

View on SEC.gov

MARAVAI LIFESCIENCES HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001823239-22-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.